A randomized controlled trial for Xiao-Qing-Long Decoction in the treatment of refractory asthma

Hospital of Chengdu University of Traditional Chinese Medicine0 个研究点开始时间: 待定最近更新: 2023年2月20日

适应症

试验速览

暂无简介。

•1. Agde 18-65 years men or women, diagnosis of bronchial asthma for at least 1 year;
•2. Patients conform to the diagnostic criteria of Western medicine refractory asthma;
•3. Patients conform to the diagnostic standard of Chinese medicine asthma External Cold and Internal Fluid Syndrome;
•4. Patients own good ability to read, understand and write research-related materials and comply with all trail requirements on a voluntary basis;
•5. Patients voluntarily participate in research and sign informed consent form.

•1. Patients have a respiratory infection within 4 weeks;
•2. Patients with chronic lung diseases require intervention or treatment such as chronic obstructive pulmonary disease, interstitial lung disease, active tuberculosis, bronchial dilation ;
•3. Patients with serious primary diseases such as severe mental and psychological disorders, heart and brain vessels diseases, liver and kidney diseases, endocrine diseases, hematopoietic system diseases and malignant tumors ;
•4. Patients take antibiotics within 3 months and eat yogurt or probiotics within 1 month;
•5. Patients are unwilling or unable to change the current treatment plan;
•6. Patients are known to be allergic to trail drugs or a certain Chinese medicine of this study;
•7. Women are breastfeeding, pregnant or preparing for pregnancy;
•8. Patients have more than 15 packs per year of smoking history ;
•9. Patients have participated in other clinical studies in the past six months.

发起方

Hospital of Chengdu University of Traditional Chinese Medicine